Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
2.150
+0.040 (1.90%)
At close: Jan 22, 2026, 4:00 PM EST
2.120
-0.030 (-1.40%)
After-hours: Jan 22, 2026, 7:42 PM EST

Silexion Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2013FY 2012
Period Ending
Jan '26 Dec '24 Dec '23 Dec '13 Dec '12
7342--
Market Cap Growth
95.04%-92.33%---
Enterprise Value
-0641--
Last Close Price
2.1530.151464.75--
PB Ratio
0.96-0.8113.99--
Debt / Equity Ratio
0.29-1.130.06--
Quick Ratio
3.320.342.093.6410.47
Current Ratio
3.970.642.273.8510.64
Return on Equity (ROE)
-771.23%---116.66%-
Return on Assets (ROA)
-77.60%-193.54%--62.13%-
Return on Capital Employed (ROCE)
-103.40%1904.70%-153.00%-195.10%-58.60%
Earnings Yield
-137.56%-510.30%-11.77%--
FCF Yield
-159.71%-261.25%-10.81%--
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q